The following is a summary of “Hematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre ...
The following is a summary of “Prognostic impact of effusion in multiple body cavities after allogeneic hematopoietic stem cell transplantation,” published in the March 2025 issue of International ...
Individual factors such as disease, age, treatment before HSCT and type of conditioning should be considered in counseling patients about the likelihood of infertility. Timing of fertility ...
Wu described an allogeneic type of HSCT known as ‘haploidentical ... to form blood clots by clumping together with platelets. TTP episodes, caused by ADAMTS13 deficiency, could range from ...
FDA has provided input on key elements of the SER-155 allo-HSCT clinical development plans including support for the proposed primary efficacy ...
Considering taking supplements to treat hematopoietic stem cell transplant hsct? Below is a list of common natural remedies used to treat or reduce the symptoms of hematopoietic stem cell ...
Expert Rev Pharmacoeconomics Outcomes Res. 2013;13(2):227-235. †Included absence of a breakthrough fungal infection, survival for 7 days beyond end of therapy, no premature discontinuation of ...
AlloHeme test accurately predicts relapse post-allo-HSCT in AML and MDS, with a median lead time of 36 days. The ACROBAT study involved 287 patients, showing significant predictive value of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback